GTCB founding costs. My apologies if I missed this in the FAQ. Does anyone know the approximate cost for creation of a founding herd by GTCB, for company ABC who wishes to evaluate the platform in support of clinical trials, for example? Does $250k sound about right?
The issue I am thinking about is, if protein used to support clinical or preclinical work was produced in a bioreactor, will FDA/EMEA allow the switch to Goat production? Will new data demonstrating equivalency generally be required? In other words, does a company need to adopt GTCB very early in the process, or would they be able to make the switch say, after the completion of a preclinical, a phase 1, or a phase 2 trial.
The obstacle to discovery is the illusion of knowledge.
